DirectPay and iXchange Expand Cash Access in Greece Through NCR Atleos
DirectPay is a leading financial and payments services provider with more than 1,300 agent locations throughout Greece, offering MoneyGram money transfers, bill payments, cash-to-bank deposits, and a full suite of financial services. iXchange offers its customers services including foreign currency exchange, money transfers, bill payments, and more. Both companies are part of the same group.
"Our goal has always been to make financial transactions simple, accessible, and secure for all," explained Panos Spiridakos, Managing Director of DirectPay. "Atleos' Cashzone Network is recognized for its robust security, advanced capabilities, and reliable uptime, features that will help us maintain optimal service levels and customer satisfaction, while also creating new revenue opportunities and operational efficiencies."
"We have remained committed to providing our customers with seamless, reliable interactions to maintain trust and loyalty," explained Giannis Kontis, Managing Director of iXchange. "By implementing Atleos' ATMs, consumers gain a dependable, secure way to withdraw cash and conduct their tasks with convenience and ease. At the same time, our employees are able to operate more efficiently, saving time to assist customers with more complicated transactions."
"The European Central Bank (ECB)'s latest consumer payment behavior study "2024 SPACE" tells us that Greek consumers look to ATMs for their cash more than any other channel and any other Eurozone country and at the same time cite access to cash as a challenge," explained Ben Bregman, Senior Vice President, Global Network Solutions for Atleos. "By expanding access through the Cashzone Network, DirectPay and iXchange offer a secure, efficient, and easy-to-use cash access platform within familiar retail environments, reducing consumer friction in accessing their accounts and growing loyalty."
About Atleos
Atleos (NYSE: NATL) is a leader in expanding self-service financial access, with industry-leading ATM expertise and experience, unrivalled operational scale including the largest independently-owned ATM network, always-on global services and constant innovation. Atleos improves operational efficiency for financial institutions, drives footfall for retailers and enables digital-first financial self-service experiences for consumers. Atleos was ranked #12 in Newsweek's prestigious 2025 Top 100 Global Most Loved Workplaces® list. Atleos is headquartered in Atlanta, Ga., with approximately 20,000 employees globally. For more information, visit www.ncratleos.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250701520926/en/
Contacts
Media Contact Scott SykesNCR Atleosscott.sykes@ncratleos.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Report – Inter Milan & Roma Were Ready To Agree Deal For France Star Before U-Turn
Inter Milan and Roma reportedly had an agreement for midfielder Manu Kone before a u-turn by the Giallorossi. This according to Italian outlet They report that Roma owners the Friedkins were crucial to the decision to walk away from negotiations to sell the Frenchman. Yesterday, news emerged that Inter Milan are interested in Roma midfielder Manu Kone. The Frenchman has come into the Nerazzurri's sights as a reinforcement in holding midfield. Reports indicate that Inter put a bid of around €45 million on the table. However, Roma have decided to reject that offer from the Nerazzurri. They have, for all intents and purposes, taken Kone off the market this summer. Report – Inter & Roma Had Manu Kone Agreement Before U-Turn MILAN, ITALY – NOVEMBER 17: Manu Kone' of France in action during the UEFA Nations League 2024/25 League A Group A2 match between Italy and France at on November 17, 2024 in Milan, Italy. (Photo by) According to the Gazzetta dello Sport, though, Roma had initially been open to selling Kone. Inter approached the Giallorossi recently. And they received permission to start negotiating with the player. And Kone himself would have been more than willing to make the move. The 24-year-old had an informal agreement with the Nerazzurri already. However, today Roma have made something of an about face as far as Inter's interest in Kone. The Giallorossi board spent the day discussing the possibility of selling the France international internally. On the one hand, a big fee for Kone would have financed some transfer business the other way, including signings of Jadon Sancho and Leon Bailey. The Gazzetta report that even Roma coach Gian Piero Gasperini would have been willing to make the sale. However, the Gazzetta dello Sport report, Roma owner Dan Friedkin pulled the plug. After seeing what the fan reaction was and considering the importance of Kone to the team, he decided that Kone is not for sale this summer.
Yahoo
an hour ago
- Yahoo
Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst
Eli Lilly (LLY) raised prices of its GLP-1 weight-loss injectable in the UK this week, with plans to do the same in other European countries, in response to President Trump's push to normalize pricing in peer developed nations. The effort, known as Most Favored Nations pricing, has been a goal of Trump's since his first term. He has doubled down on the efforts this year, giving pharma companies 60 days to implement changes in pricing in what he deems "freeloading" nations. The US drug economy differs from European and other developed nations, which rely on the government to negotiate prices with drugmakers, resulting in lower prices globally. "While we agree that the costs for breakthrough medicines should be more fairly shared across developed countries, we must also address the underlying structural issues in the US that have contributed to high drug prices. The US system is complex and opaque," Lilly said in a statement Thursday. The stock was up 1% in trading Friday. Eli Lilly raised the price of its GLP-1, Zepbound, from about $125 to $165 and plans an additional hike next month that would almost double its price. In a note to clients Friday, Bank of America Securities research analyst Tim Anderson questioned who would actually be impacted by the raised prices. "LLY has announced it will raise GLP-1 pricing in the UK by a healthy margin (a doubling of price, but it's unclear to whom this higher price realistically applies). It expects to do something similar in other European countries (but worth appreciating: in most European markets, there aren't price agreements in place between GLP-1 manufacturers and governments, meaning these are out-of-pocket spending markets)," Anderson wrote. Ultimately, whether or not the move results in lower US prices remains a question, though Anderson believes it likely will not. "Does this mean it will actually cut the price on the GLP-1s in the US (and on other medicines)? To us, the answer is quite likely no, or at least, not in a way that creates P&L [profit and loss planning ] risk," he wrote. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Villarreal offer ‘short of expectations' for Chelsea defender Renato Veiga — report
Villarreal were linked with unwanted Chelsea defender Axel Disasi earlier this summer, and though nothing came of that, they are still in need of reinforcements at the position and have thus switched their target to unwanted Chelsea defender Renato Veiga instead — and according to Fabrizio Romano, have even made an official play for their 'dream target'. Unfortunately, back in the real world, it sounds like the financial realities of the situation remain the same as before. The La Liga side were not willing or able to spend €30m on Disasi — their record incoming transfer is barely over €20m — and Chelsea are said to be wanting even more for Veiga (€40?!). Whatever their bid is now, it's fallen short of our 'expectations'. This is the trouble in trying to do business outside of England (or Saudi Arabia) or with teams that are not among the European elite. The Premier League (top to bottom) are so far above of most other leagues financially that it becomes an exercise in futility. The levels of money are simply different, even if they are willing to spend. Villarreal finished fifth last season, but were still able to nab a Champions League spot (Spain, like England, get an extra spot thanks to their UEFA coefficient). So perhaps that little boost in income can be turned into a bit of extra cash for Veiga?
